Gregory Zuckerman examines the global race between Oxford-AstraZeneca, Pfizer-BioNTech, and J&J, emphasizing the different scientific approaches and the logistical advantages of one-shot vaccines. 6

Season 8, Episode 493,   Feb 22, 03:26 AM